Modifiable vascular risk factors, white matter disease and cognition in early Parkinson's disease.

Saved in:
Bibliographic Details
Title: Modifiable vascular risk factors, white matter disease and cognition in early Parkinson's disease.
Authors: Chahine, L. M., Dos Santos, C., Fullard, M., Scordia, C., Weintraub, D., Erus, G., Rosenthal, L., Davatzikos, C., McMillan, C. T.
Source: European Journal of Neurology. Feb2019, Vol. 26 Issue 2, p246-246. 1p. 1 Black and White Photograph, 4 Charts.
Subjects: Parkinson's disease, Mild cognitive impairment, Alzheimer's disease, Brain diseases, Neurodegeneration
Abstract: Background and purpose: Dementia in Parkinson's disease (PD) is common and disabling. Identification of modifiable risk factors for it is essential. Vascular risk factors (VRFs) may be associated with cognitive decline in early PD. Biomarkers that serve as surrogates of the long‐term effect of VRFs on PD are needed. To that end, we aimed to quantitate white matter hyperintensities (WMH) in early PD, measure associations with VRFs and examine relationships between WMH and longitudinal cognition. Methods: Participants in the Parkinson's Progression Markers Initiative study (141 patients with PD, 63 healthy controls) with adequate baseline structural brain magnetic resonance imaging data were included. Hypertension and diabetes history, and body mass index were combined to create a vascular risk score. WMH were quantitated via automated methods. Cognition was assessed annually with a comprehensive test battery. Results: In the PD group, vascular risk score was associated with WMH for total brain (β = 0.210; P = 0.021), total white matter (β = 0.214; P = 0.013), frontal (β = 0.220; P = 0.002) and temporal (β = 0.212; P = 0.002) regions. Annual rate of change in global cognition was greater in those with higher vascular risk score (β = −0.040; P = 0.007) and greater WMH (β = −0.029; P = 0.049). Higher temporal WMH burden was associated with great decline over time in verbal memory (β = −0.034; P = 0.031). Conclusions: In early PD, modifiable VRFs are associated with WMH on brain magnetic resonance imaging. Temporal WMH burden predicts decline in verbal memory. WMH may serve as a surrogate marker for the effect of VRFs on cognitive abilities in PD. [ABSTRACT FROM AUTHOR]
Copyright of European Journal of Neurology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 134091373
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Modifiable vascular risk factors, white matter disease and cognition in early Parkinson's disease.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Chahine%2C+L%2E+M%2E%22">Chahine, L. M.</searchLink><br /><searchLink fieldCode="AR" term="%22Dos+Santos%2C+C%2E%22">Dos Santos, C.</searchLink><br /><searchLink fieldCode="AR" term="%22Fullard%2C+M%2E%22">Fullard, M.</searchLink><br /><searchLink fieldCode="AR" term="%22Scordia%2C+C%2E%22">Scordia, C.</searchLink><br /><searchLink fieldCode="AR" term="%22Weintraub%2C+D%2E%22">Weintraub, D.</searchLink><br /><searchLink fieldCode="AR" term="%22Erus%2C+G%2E%22">Erus, G.</searchLink><br /><searchLink fieldCode="AR" term="%22Rosenthal%2C+L%2E%22">Rosenthal, L.</searchLink><br /><searchLink fieldCode="AR" term="%22Davatzikos%2C+C%2E%22">Davatzikos, C.</searchLink><br /><searchLink fieldCode="AR" term="%22McMillan%2C+C%2E+T%2E%22">McMillan, C. T.</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22European+Journal+of+Neurology%22">European Journal of Neurology</searchLink>. Feb2019, Vol. 26 Issue 2, p246-246. 1p. 1 Black and White Photograph, 4 Charts.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Parkinson's+disease%22">Parkinson's disease</searchLink><br /><searchLink fieldCode="DE" term="%22Mild+cognitive+impairment%22">Mild cognitive impairment</searchLink><br /><searchLink fieldCode="DE" term="%22Alzheimer's+disease%22">Alzheimer's disease</searchLink><br /><searchLink fieldCode="DE" term="%22Brain+diseases%22">Brain diseases</searchLink><br /><searchLink fieldCode="DE" term="%22Neurodegeneration%22">Neurodegeneration</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Background and purpose: Dementia in Parkinson's disease (PD) is common and disabling. Identification of modifiable risk factors for it is essential. Vascular risk factors (VRFs) may be associated with cognitive decline in early PD. Biomarkers that serve as surrogates of the long‐term effect of VRFs on PD are needed. To that end, we aimed to quantitate white matter hyperintensities (WMH) in early PD, measure associations with VRFs and examine relationships between WMH and longitudinal cognition. Methods: Participants in the Parkinson's Progression Markers Initiative study (141 patients with PD, 63 healthy controls) with adequate baseline structural brain magnetic resonance imaging data were included. Hypertension and diabetes history, and body mass index were combined to create a vascular risk score. WMH were quantitated via automated methods. Cognition was assessed annually with a comprehensive test battery. Results: In the PD group, vascular risk score was associated with WMH for total brain (β = 0.210; P = 0.021), total white matter (β = 0.214; P = 0.013), frontal (β = 0.220; P = 0.002) and temporal (β = 0.212; P = 0.002) regions. Annual rate of change in global cognition was greater in those with higher vascular risk score (β = −0.040; P = 0.007) and greater WMH (β = −0.029; P = 0.049). Higher temporal WMH burden was associated with great decline over time in verbal memory (β = −0.034; P = 0.031). Conclusions: In early PD, modifiable VRFs are associated with WMH on brain magnetic resonance imaging. Temporal WMH burden predicts decline in verbal memory. WMH may serve as a surrogate marker for the effect of VRFs on cognitive abilities in PD. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of European Journal of Neurology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=134091373
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/ene.13797
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 1
        StartPage: 246
    Subjects:
      – SubjectFull: Parkinson's disease
        Type: general
      – SubjectFull: Mild cognitive impairment
        Type: general
      – SubjectFull: Alzheimer's disease
        Type: general
      – SubjectFull: Brain diseases
        Type: general
      – SubjectFull: Neurodegeneration
        Type: general
    Titles:
      – TitleFull: Modifiable vascular risk factors, white matter disease and cognition in early Parkinson's disease.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Chahine, L. M.
      – PersonEntity:
          Name:
            NameFull: Dos Santos, C.
      – PersonEntity:
          Name:
            NameFull: Fullard, M.
      – PersonEntity:
          Name:
            NameFull: Scordia, C.
      – PersonEntity:
          Name:
            NameFull: Weintraub, D.
      – PersonEntity:
          Name:
            NameFull: Erus, G.
      – PersonEntity:
          Name:
            NameFull: Rosenthal, L.
      – PersonEntity:
          Name:
            NameFull: Davatzikos, C.
      – PersonEntity:
          Name:
            NameFull: McMillan, C. T.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: Feb2019
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-print
              Value: 13515101
          Numbering:
            – Type: volume
              Value: 26
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: European Journal of Neurology
              Type: main
ResultId 1